Recently we got information from the WHO (The world health organization) about the remdesivir antiviral drug. That it will now not be used in critical condition patients instead Pfizers new vaccine will be used in these patients.
As you would expect this caused multiple issues and disagreements. Firstly it caused Gilead’s stock price to fall quite rapidly. This also lead to many disputes with first responders and other medical personal as they now had to get rid of all the remdesivir they had and then they bought new doses of Pfizers vaccine. Finally this lead to many disagreements not only between countries but also other companies that wanted their vaccine to be used instead or companies that supported Gileads antiviral drug over Pfizers or vice versa.